Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
D000284:Administration, Oral; D000526:Alprenolol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D003864:Depression, Chemical; D004562:Electrocardiography; D005080:Exercise Test; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D010417:Pentaerythritol Tetranitrate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010701:Phonocardiography; D005082:Physical Exertion / Q000187:drug effects; D010919:Placebos; D013268:Stimulation, Chemical
D003692:Delayed-Action Preparations; D010919:Placebos; D010417:Pentaerythritol Tetranitrate; D000526:Alprenolol; D002784:Cholesterol; D005996:Nitroglycerin